跳至主要内容
临床试验/NCT01662232
NCT01662232已完成不适用

The Role of EGCG in Different Application Forms on Flow-mediated Dilation in Healthy Volunteers

Charite University, Berlin, Germany1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
Flow-mediated dilation of the arteria brachialis

研究概览

简要总结

Cardiovascular diseases are a major cause of morbidity and mortality worldwide. Impaired endothelial function (assessed as flow-mediated dilation) represents an early marker for later cardiovascular events. Epidemiological and experimental studies suggest that consumption of tea is associated with lower progression of atherosclerosis and reduced cardiovascular mortality.

Tea contains high amounts of polyphenols with important biological activities. The green tea catechin epigallocatechin-3-gallate (EGCG) is the most potent physiologically active compound in vitro. However, little is known about its contribution to beneficial effects of tea in vivo.

In this crossover study the impact of a single dose of EGCG applied in different forms (green tea beverage, green tea extract and EGCG) on flow-mediated dilation is investigated in healthy volunteers two hours after ingestion. The amount of EGCG (200 mg) corresponds to appr. 0.5 L of green tea. The results of the study will elucidate the contribution of EGCG in cardiovascular protective effects of green tea in vivo. The outcomes will provide insights about the role of EGCG in different application forms to improvements of endothelial function in humans.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Male healthy volunteers
  • •20-50 years
  • •BMI < 27 kg/m2
  • •Cholesterol < 240 mg/dl

排除标准

  • •Diabetes mellitus
  • •Hypertension
  • •Conditions with impaired endothelial function
  • •Regular drug use
  • •Alcohol abuse
  • •Regular tea drinkers

研究组 & 干预措施

Epigallocatechin-3-gallate (EGCG)

Active Comparator

200 mg EGCG and same volume water as for tea beverage.

干预措施: EGCG (Dietary Supplement)

Green tea beverage

Active Comparator

200 mg EGCG as green tea beverage.

干预措施: Green tea beverage (Dietary Supplement)

Placebo (Water)

Placebo Comparator

Same volume water as for all intervention arms.

干预措施: Placebo (Other)

Green tea extract

Active Comparator

200 mg EGCG as green tea extract and same volume water as for tea beverage.

干预措施: Green tea extract (Dietary Supplement)

结局指标

主要结局

Flow-mediated dilation of the arteria brachialis

时间窗: 2 hours after ingestion

Change in flow-mediated dilation (in %) of the arteria brachialis after a single dose of 200 mg EGCG either as green tea beverage, green tea extract or EGCG is assessed by vascular ultrasound.

次要结局

  • Agonist-induced platelet aggregation in vitro(2 hours after ingestion)
  • Determination of plasma tea polyphenol levels(2 hours after ingestion)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mario Lorenz, PhD

PhD

Charite University, Berlin, Germany

研究点 (1)

Loading locations...

相似试验